Invention Grant
- Patent Title: Phenyl derivatives as cannabinoid receptor 2 agonists
-
Application No.: US16930013Application Date: 2020-07-15
-
Publication No.: US11339120B2Publication Date: 2022-05-24
- Inventor: Olivier Gavelle , Uwe Grether , Matthias Nettekoven , Stephan Roever , Mark Rogers-Evans , Didier Rombach
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Zong-Qiang Bill Tian
- Priority: EP15198733 20151209
- Main IPC: C07D207/16
- IPC: C07D207/16 ; C07D231/12 ; C07D401/10 ; C07D403/10 ; C07D413/06 ; C07D413/10 ; C07D413/12 ; C07D205/04 ; C07C235/52 ; C07D331/04 ; C07D271/06 ; C07D213/61 ; C07D209/54 ; C07D305/06 ; C07D207/14 ; C07D277/30 ; C07C235/48 ; C07C237/22 ; C07C231/02 ; C07D207/10 ; C07D277/28 ; C07D305/08
Abstract:
The invention relates to a compound of formula (I) wherein R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
Public/Granted literature
- US20210171441A1 PHENYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS Public/Granted day:2021-06-10
Information query
